Prospects and problems in the production of 143Pr for radionuclide therapy applications

Radiochimica Acta

Volumn 93, Issue 7, 2005, Pages 419-426

  Vimalnath, K V ^a   Das, M K ^b   Venkatesh, Meera ^a   Ramamoorthy, N ^a,c  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

^b VARIABLE ENERGY CYCLOTRON CENTRE   (India)

^c INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

Author keywords

143Ce; End of irradiation (EOI); Gamma ray spectrometry; Hydroxyapatite (HA); No carrier added (nca) 143Pr; Radionuclide therapy (RNT)

Indexed keywords

EID: 22444443819     PISSN: 00338230     EISSN: None     Source Type: Journal    
DOI: 10.1524/ract.2005.93.7.419     Document Type: Article

References (34)

1. Therapeutic applications of radiopharmaceuticals: IAEA-TECDOC-1228, International Atomic Energy Agency, Vienna (2001).
2. Volkert, W. A., Goeckeler, W. F., Ehrhardt, G. J., Ketring, A. R.: Therapeutic radionuclides: Production and decay property consideration. J. Nucl. Med. 32, 174 (1991).
3. Meera Venkatesh, Pillai, M. R. A., Ramamoorthy. N.: Prospects and challenges in production of radionuclides for therapy in "Utilisation of research reactors". IANCAS Bulletin, BARC, Mumbai (2002) pp. 78-84.
4. Tuli, J. K.: Nuclear Wallet Cards. Brookhaven National Laboratory, USA (2000).
5. th Edn. (Firestone, R. B., ed.) John Wiley and Sons (1999).
6. 186Re-HEDP as bone therapeutic radiopharmaceuticals. Nucl. Med. Biol. 14, 223 (1987).
7. Shortkroff, S., Mahmood, A., Sledge, C. B., Jones, A. G., Broadack, J. W., Chinen, L. K., Deutsch, E., Deutsch, K. F.: Studies on Ho-166-labelled hydroxyapatite: A new agent for radiation synovectomy. J. Nucl. Med. 33, 937 (1992).
8. Brodack, J. N., Chinen, L. K., Deutsch, E., Deutsch, K. F.: Studies on the radiolabelling of hydroxyapatite particles for use as radiation synovectomy agent. J. Nucl. Med. 33, 980 (1992).
9. Chinol, M., Vallabhajosula, S., Goldsmith, S. J., Klein, M. J., Deutsch, K. F., Chinen, L. K., Brodack, J. M., Deutsch, E. A., Watson, B. A., Tofe, A. J.: Chemistry and biological behaviour of Samarium-153 and Rhenium-186-labeled hydroxyapatite particles: Potential radiopharmaceuticals for radiation synovectomy. J. Nucl. Med. 34, 1536 (1993).
10. Clunie, G., Lui, D., Cullam, I., Edwards, C. W., Ell, P. J.: Samarium-153-particulate hydroxyapatite radiation synovectomy: Biodistribution data for chronic knee synovitis. J. Nucl. Med. 36, 51 (1995).
11. 166Ho labelled hydroxyapatite (HA) particles for radiosynovectomy. Nucl. Med. Biol. 29, 199 (2002).
12. 90Y-labelled particles for use in radiation synovectomy. Appl. Radiat. Isot. 55, 471 (2001).
13. 32P-colloidal chromic phosphate in rheumatoid arthritis. J. Rheum. 9, 229 (1982).
14. Rivard, G. E., Girard, M., Cliché, C. L., Guay, J. P., Belanger, R., Besner, R.: Synoviorthesis in patients with haemophilia and inhibitors. Can. Med. Assoc. J. 127, 41 (1982).
15. Vimalnath, K. V.: Studies on the reactor production and separation of some radionuclides of medical interest. MSc Thesis, University of Mumbai (2003).
16. Masumitsu Kubota.: Preparation of high purity praseodymium-143 from neutron irradiated cerium oxide by cation-exchange separation. J. Nucl. Sci. Tech. 13, 492 (1976).
17. Feigl, F.: Qualitative analysis by spot tests. Elsevier Publishing Company, New York, Amsterdam (1946) pp. 160-162.
18. 153Sm of radionuclide therapy. Nucl. Med. Commun. 23, 83 (2002).
19. 177Lu for radionuclide therapy. Appl. Radiat. Isot. 59, 109 (2003).
20. 144Pr - a radiochemistry demonstration. J. Chem. Edu. 36, 136 (1959).
21. 144Ce. Sep. Sci. II(5), 503 (1976).
22. Harbert, J. C.: Nuclear Medicine Therapy. Thieme Medical Publishers, Inc., New York (1987).
23. Zweit, J.: Radionuclides and carrier molecules for therapy. Phys. Med. Biol. 41, 1905 (1996).
24. Ott, R. J.: Imaging technologies for radionuclide dosimetry. Phys. Med. Biol. 41, 1885 (1996).
25. Coursey, B. M. (Ed.): Radionuclides for bone palliation. Appl. Radiat. Isot. 49, 275-356 (1998).
26. 89Sr in palliation in skeletal metastases. J. Nucl. Med. 40, 256 (1999).
27. Lee, J. D., Park, K. K., Lee, M. G., Kim, E. H., Rihm, K. J., Lee, J. T., Yoo, H. S., Kim, H. S., Park, K. B., Kim, J. R.: Radionuclide therapy of skin cancers and Bowen's disease using a specially designed skin patch. J. Nucl. Med. 38, 697 (1997).
28. 90Y skin patches for therapy of superficial tumours in mice. Nucl. Med. Commun. 23, 243 (2002).
29. Mukherjee, A., Pandey, U., Sarma, H. D., Gupta, S. K., Ingle, A. D., Pillai, M. R. A., Venkatesh, M.: Bioevaluation of radioactive bandages in a murine model of melanoma. Int. J. Radiat. Biol. 79, 1 (2003).
30. Kampen, W. U., Brenner, W., Czech, N., Henze, E.: Intraarticular application of unsealed beta emitting radionuclides in the treatment course of inflammatory joint diseases. C. Med. Chem. 1, 77 (2002).
31. Silberstein, E. B., Elgazzar, A. H., Kapilivsky, A.: Phosphorus-32 radiopharmaceuticals for the treatment of painful osseous metastases. Semin. Nucl. Med. 22, 17 (1992).
32. 32P) chromic phosphate for treatment of solid tumors. Act. Physiol. Pharmacol. Ther. Lat. 46, 103 (1996).
33. Fettich, J., Nair, G., Padhy, A. K., Stare, J., Nair, N., Moralles, R.: 32-Phosphorus for bone pain palliation due to metastases, its safety and efficacy in patients with advanced cancer in therapeutic applications of radiopharmaceuticals. IAEA-TECDOC-1228, International Atomic Energy Agency, Vienna (2001) pp. 193-198.
34. 32P for the treatment of solid tumours, therapeutic action and radiodosimetric calculations in therapeutic applications of radiopharmaceuticals. IAEA-TECDOC-1228, International Atomic Energy Agency, Vienna (2001) pp. 275-282.